B-type natriuretic peptide and platelet parameters change in patients with chronic heart failure

Fang Chuanhua,Lu Daru,Xiong Lifan
DOI: https://doi.org/10.3969/j.issn.1673-4130.2013.20.014
2013-01-01
Abstract:Objective To observe the changes in patients with chronic heart failure by assaying plasma B-type natriuretic peptide concentration and platelet parameters in blood routine examination,and to assess the diagnosis value of BNP in patient with CHF by using ROC curve.Methods 353 patients with CHF in our department of cardiology and 40 patients with non-CHF were selected in this study.All patients underwent physical examination,electrocardiogram,blood sampling for examination of serum B-type natriuretic peptide and a complete blood count.Results There was no significant difference between CHF group and non-CHF group about gender,age,platelet counts(PLT),plateletcrit(PCT)and mean platelet volume(MPV),platelet distribution width(PDW)(P>0.05),platelet-large cell ratio(P-LCR)in CHF group were significantly higher than that of non-CHF group(P<0.01).Plasma BNP test results with the increase of NYMA graded gradually from low to high,which classⅠand classⅡthere was no statistically significant difference(P>0.05).There was visible difference between classⅡand classⅢ,as well as classⅢand classⅣ(P<0.001).CHF group,the area under the ROC curve was 0.73(95%CI:0.67-0.80).The sensitivity and specificity of BNP were64%,85% respectively(cutoff:68pg/mL).Conclusion Extent of plasma BNP in patients with CHF,PDW,P-LCR,MPV,blood platelet parameters,such as joint BNP testing as the CHF patients provide valuable reference for clinical diagnosis.
What problem does this paper attempt to address?